Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel-Reference-Cited by-同舟云学术

Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel

Published:2018-12-02 Issue:1 Volume:49 Page:7-19
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Guo Chuan-Guo¹^ORCID,Chen Lijia¹,Chan Esther W.²,Cheung Ka Shing¹,Isshiki Takaaki³,Wong Ian C. K.²,Leung Wai K.¹

Affiliation:

1. Department of Medicine, Li Ka Shing Faculty of Medicine; University of Hong Kong; Hong Kong China

2. Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine; University of Hong Kong; Hong Kong China

3. Cardiovascular Center; Ageo Central General Hospital; Ageo Saitama Japan

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15059/fullpdf

Reference77 articles.

1. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Kushner;Circulation,2009

2. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Jneid;J Am Coll Cardiol,2012

3. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement;Hochholzer;J Am Coll Cardiol,2006

4. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes;Storey;J Am Coll Cardiol,2007

5. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties;Sugidachi;Br J Pharmacol,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor;Frontiers in Pharmacology;2024-04-09

2. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease;Nature Reviews Cardiology;2024-03-20

3. Predictors of gastrointestinal bleeding in patients with acute coronary syndrome and the optimal duration of dual antiplatelet therapy;Journal of Research in Medical Sciences;2024-03

4. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view;World Journal of Cardiology;2023-08-26

5. Short dual antiplatelet therapy in patients with high bleeding risk undergoing percutaneous coronary intervention: a systematic review and meta-analysis;Coronary Artery Disease;2022-09-22